ACC 22: Findings From the PARTITA Trial | Dr Paolo Della Bella

Подробнее о видео

Watch on Radcliffe Cardiology:

In this short interview from ACC 2022, Dr Paolo Della Bella (San Raffaele University-Hospital, Milan, Italy) joins us to discuss the findings of the PARITA trial. The aim of this study was to determine whether the burden of ventricular tachycardia correlates with ICD shock therapies and if the timing of VT ablation affects patient prognosis.

Discussion Points:

1. Rationale behind this trial
2. Patient cohort and study design
3. Key findings
4. Influence on clinical practice
5. Next steps
6. Take-home messages

Recorded on-site in Washington DC, ACC Conference 2022.
Interviewer: Mirjam Boros
Editor: Jordan Rance

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.